Thu, 31 August 2017
We review gastroparesis treatment with haloperidol including a recent study by Ramirez and colleagues. This study had significant methodologic limitations but provides some interesting insight into a practice that many providers have adopted - using haloperidol for gastroparesis. A tiny RCT by Roldan and colleagues also looked at this practice and found promising results, although the study was very small. Haloperidol has also been used in cannabinoid hyperemesis but literature on this is limited to case reports/series.
We also cover core content on biliary pathology using Tintinalli and Rosen's as guides.
Thanks for listening!